Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1983 Jun;38(6):401–407. doi: 10.1136/thx.38.6.401

Immunotherapy in respiratory allergy.

R J Davies
PMCID: PMC459575  PMID: 6879494

Full text

PDF
401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aas K. Hyposensitization in house dust allergy asthma. A double-blind controlled study with evaluation of the effect on bronchial sensitivity to house dust. Acta Paediatr Scand. 1971 May;60(3):264–268. doi: 10.1111/j.1651-2227.1971.tb06655.x. [DOI] [PubMed] [Google Scholar]
  2. Anaphylactic reaction to desensitisation. Br Med J. 1980 Nov 22;281(6252):1429–1429. doi: 10.1136/bmj.281.6252.1429-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARR S. E., BROWN H., FUCHS M., ORVIS H., CONNOR A., MURRAY F. J., SELTZER A. A DOUBLE-BLIND STUDY OF THE EFFECTS OF BACTERIAL VACCINE ON INFECTIVE ASTHMA. J Allergy. 1965 Jan-Feb;36:47–61. doi: 10.1016/0021-8707(65)90032-8. [DOI] [PubMed] [Google Scholar]
  4. Berg T., Nordvall S. L., Lanner A. Clinical studies of a purified timothy pollen extract. Desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. I. Results of tests in vivo. Int Arch Allergy Appl Immunol. 1980;63(3):266–274. [PubMed] [Google Scholar]
  5. Bruce C. A., Norman P. S., Rosenthal R. R., Lichtenstein L. M. The role of ragweed pollen in autumnal asthma. J Allergy Clin Immunol. 1977 Jun;59(6):449–459. doi: 10.1016/0091-6749(77)90009-4. [DOI] [PubMed] [Google Scholar]
  6. Chapman M. D., Platts-Mills T. A. Purification and characterization of the major allergen from Dermatophagoides pteronyssinus-antigen P1. J Immunol. 1980 Aug;125(2):587–592. [PubMed] [Google Scholar]
  7. Connell J. T., Sherman W. B. Changes in skin-sensitizing antibody titer after injections of aqueous pollen extract. J Allergy. 1969 Jan;43(1):22–32. doi: 10.1016/0021-8707(69)90017-3. [DOI] [PubMed] [Google Scholar]
  8. D'Souza M. F., Pepys J., Wells I. D., Tai E., Palmer F., Overell B. G., McGrath I. T., Megson M. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects. Clin Allergy. 1973 Jun;3(2):177–193. doi: 10.1111/j.1365-2222.1973.tb01320.x. [DOI] [PubMed] [Google Scholar]
  9. Davies R. J., Moodley I. Antiallergic compounds. Pharmacol Ther. 1982;17(3):279–297. doi: 10.1016/0163-7258(82)90018-3. [DOI] [PubMed] [Google Scholar]
  10. FRANKLAND A. W., AUGUSTIN R. Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component. Lancet. 1954 May 22;266(6821):1055–1057. doi: 10.1016/s0140-6736(54)91620-7. [DOI] [PubMed] [Google Scholar]
  11. FRANKLAND A. W., HUGHES W. H., GORRILL R. H. Autogenous bacterial vaccines in treatment of asthma. Br Med J. 1955 Oct 15;2(4945):941–944. doi: 10.1136/bmj.2.4945.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gabriel M Sister, Ng H. K., Allan W. G., Hill L. E., Nunn A. J. Study of prolonged hyposensitization with D. pteronyssinus extract in allergic rhinitis. Clin Allergy. 1977 Jul;7(4):325–339. doi: 10.1111/j.1365-2222.1977.tb01460.x. [DOI] [PubMed] [Google Scholar]
  13. Georgitis J. W., Reisman R. E., Clayton W. F., Mueller U. R., Wypych J. I., Arbesman C. E. Local intranasal immunotherapy for grass-allergic rhinitis. J Allergy Clin Immunol. 1983 Jan;71(1 Pt 1):71–76. doi: 10.1016/0091-6749(83)90549-3. [DOI] [PubMed] [Google Scholar]
  14. Gleich G. J., Jacob G. L., Yunginger J. W., Henderson L. L. Measurement of the absolute levels of IgE antibodies in patients with ragweed hay fever. J Allergy Clin Immunol. 1977 Sep;60(3):188–198. doi: 10.1016/0091-6749(77)90123-3. [DOI] [PubMed] [Google Scholar]
  15. Graham V. A., Milton A. F., Knowles G. K., Davies R. J. Routine antibiotics in hospital management of acute asthma. Lancet. 1982 Feb 20;1(8269):418–420. doi: 10.1016/s0140-6736(82)91619-1. [DOI] [PubMed] [Google Scholar]
  16. Hill D. J., Hosking C. S., Shelton M. J., Turner M. W. Failure of hyposensitisation in treatment of children with grass-pollen asthma. Br Med J (Clin Res Ed) 1982 Jan 30;284(6312):306–309. doi: 10.1136/bmj.284.6312.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ishizaka K., Okudaira H., King T. P. Immunogenic properties of modified antigen E. II. Ability of urea-denatured antigen and alpha-polypeptide chain to prime T cells specific for antigen E. J Immunol. 1975 Jan;114(1 Pt 1):110–115. [PubMed] [Google Scholar]
  18. JOHNSTONE D. E. Study of the role of antigen dosage in the treatment of pollenosis and pollen asthma. AMA J Dis Child. 1957 Jul;94(1):1–5. doi: 10.1001/archpedi.1957.04030020003001. [DOI] [PubMed] [Google Scholar]
  19. Johansson S. G., Miller A. C., Mullan N., Overell B. G., Tees E. C., Wheeler A. Glutaraldehyde-pollen-tyrosine: clinical and immunological studies. Clin Allergy. 1974 Sep;4(3):255–263. doi: 10.1111/j.1365-2222.1974.tb01383.x. [DOI] [PubMed] [Google Scholar]
  20. Kemler B. J., Franklin W. D., Alpert E., Bloch K. J. Failure to detect circulating immune complexes in allergic patients on injection therapy. Clin Allergy. 1979 Sep;9(5):473–478. doi: 10.1111/j.1365-2222.1979.tb02511.x. [DOI] [PubMed] [Google Scholar]
  21. Koehler P. B. Immunotherapy in ragweed hay fever. J Allergy. 1968 Apr;41(4):237–239. doi: 10.1016/0021-8707(68)90049-x. [DOI] [PubMed] [Google Scholar]
  22. Lee W. Y., Sehon A. H. Abrogation of reaginic antibodies with modified allergens. Nature. 1977 Jun 16;267(5612):618–619. doi: 10.1038/267618a0. [DOI] [PubMed] [Google Scholar]
  23. Levinson A. I., Summers R. J., Lawley T. J., Evans R., 3rd, Frank M. M. Evaluation of the adverse effects of long-term hyposensitization. J Allergy Clin Immunol. 1978 Aug;62(2):109–114. doi: 10.1016/0091-6749(78)90087-8. [DOI] [PubMed] [Google Scholar]
  24. Lichtenstein L. M. An evaluation of the role of immunotherapy in asthma. Am Rev Respir Dis. 1978 Feb;117(2):191–197. doi: 10.1164/arrd.1978.117.2.191. [DOI] [PubMed] [Google Scholar]
  25. Lichtenstein L. M., Ishizaka K., Norman P. S., Sobotka A. K., Hill B. M. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest. 1973 Feb;52(2):472–482. doi: 10.1172/JCI107204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lichtenstein L. M., Valentine M. D., Sobotka A. K. Insect allergy: the state of the art. J Allergy Clin Immunol. 1979 Jul;64(1):5–12. doi: 10.1016/0091-6749(79)90075-7. [DOI] [PubMed] [Google Scholar]
  27. Lowell F. C., Franklin W. A double-blind study of the effectiveness and specificity of injecton therapy in ragweed hay fever. N Engl J Med. 1965 Sep 23;273(13):675–679. doi: 10.1056/NEJM196509232731302. [DOI] [PubMed] [Google Scholar]
  28. Løwenstein H. Immunological partial identity and in vitro inhibitory effect of two major timothy pollen allergens to whole pollen extract of four grasses. Int Arch Allergy Appl Immunol. 1978;57(4):379–383. doi: 10.1159/000232128. [DOI] [PubMed] [Google Scholar]
  29. McAllen M. K., Heaf P. J., McInroy P. Depot grass-pollen injections in asthma: effect of repeated treatment on clinical response and measured bronchial sensitivity. Br Med J. 1967 Jan 7;1(5531):22–25. doi: 10.1136/bmj.1.5531.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Metzger W. J., Turner E., Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol. 1978 Apr;61(4):268–272. doi: 10.1016/0091-6749(78)90202-6. [DOI] [PubMed] [Google Scholar]
  31. Miller A. C., Tees E. C. A metabolizable adjuvant: clinical trial of grass pollen-tyrosine adsorbate. Clin Allergy. 1974 Mar;4(1):49–55. doi: 10.1111/j.1365-2222.1974.tb01362.x. [DOI] [PubMed] [Google Scholar]
  32. Milner F. H., Tees E. C. Specific sensitivity to individual grass pollens in some hay fever patients. Clin Allergy. 1972 Mar;2(1):83–90. doi: 10.1111/j.1365-2222.1972.tb01271.x. [DOI] [PubMed] [Google Scholar]
  33. Nordvall S. L., Berg T., Johansson S. G., Lanner A. Clinical studies of a purified timothy pollen extract: desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. II. Results of the tests in vitro and their relation to symptoms and tests in vivo. Int Arch Allergy Appl Immunol. 1982;67(2):132–138. doi: 10.1159/000233003. [DOI] [PubMed] [Google Scholar]
  34. Norman P. S. An overview of immunotherapy: implications for the future. J Allergy Clin Immunol. 1980 Feb;65(2):87–96. doi: 10.1016/0091-6749(80)90191-8. [DOI] [PubMed] [Google Scholar]
  35. Norman P. S., Lichtenstein L. M., Kagey-Sobotka A., Marsh D. G. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol. 1982 Oct;70(4):248–260. doi: 10.1016/0091-6749(82)90061-6. [DOI] [PubMed] [Google Scholar]
  36. Norman P. S., Lichtenstein L. M. The clinical and immunologic specificity of immunotherapy. J Allergy Clin Immunol. 1978 Jun;61(6):370–377. doi: 10.1016/0091-6749(78)90116-1. [DOI] [PubMed] [Google Scholar]
  38. Platts-Mills T. A., von Maur R. K., Ishizaka K., Norman P. S., Lichtenstein L. M. IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release. J Clin Invest. 1976 Apr;57(4):1041–1050. doi: 10.1172/JCI108346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pruzansky J. J., Patterson R. Histamine release from leukocytes of hypersensitive individuals. II. Reduced sensitivity of leukocytes after injection therapy. J Allergy. 1967 Jan;39(1):44–50. doi: 10.1016/0021-8707(67)90126-8. [DOI] [PubMed] [Google Scholar]
  40. Rands D. A. Anaphylactic reaction to desensitisation for allergic rhinitis and asthma. Br Med J. 1980 Sep 27;281(6244):854–854. doi: 10.1136/bmj.281.6244.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Smith A. P. Hyposensitization with Dermatophagoides pteronyssinus antigen: trial in asthma induced by house dust. Br Med J. 1971 Oct 23;4(5781):204–206. doi: 10.1136/bmj.4.5781.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Taylor B., Sanders S. S., Norman A. P. A double blind controlled trial of house mite fortified house dust vaccine in childhood asthma. Clin Allergy. 1974 Mar;4(1):35–40. doi: 10.1111/j.1365-2222.1974.tb01360.x. [DOI] [PubMed] [Google Scholar]
  43. Taylor W. W., Ohman J. L., Jr, Lowell F. C. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. J Allergy Clin Immunol. 1978 May;61(5):283–287. doi: 10.1016/0091-6749(78)90048-9. [DOI] [PubMed] [Google Scholar]
  44. Treatment of house dust allergy. A report from the Research Committee of the British Tuberculosis Association. Br Med J. 1968 Sep 28;3(5621):774–777. [PMC free article] [PubMed] [Google Scholar]
  45. Vervloet D., Khairallah E., Arnaud A., Charpin J. A prospective national study of the safety of immunotherapy. Clin Allergy. 1980 Jan;10(1):59–64. doi: 10.1111/j.1365-2222.1980.tb02080.x. [DOI] [PubMed] [Google Scholar]
  46. Warner J. O. Hyposensitization in asthma: a review. J R Soc Med. 1981 Jan;74(1):60–65. [PMC free article] [PubMed] [Google Scholar]
  47. Warner J. O., Price J. F., Soothill J. F., Hey E. N. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet. 1978 Oct 28;2(8096):912–915. doi: 10.1016/s0140-6736(78)91630-6. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES